Education
About Us
Working with TipRanks
Follow Us
HAVN Life Sciences (HAVLF)
OTHER OTC:HAVLF
| Dec 21 | Dec 21 | Dec 19 | |
|---|---|---|---|
| Income Statement | |||
| Total Revenue | C$ 276.47K | C$ 0.00 | C$ 0.00 |
| Gross Profit | C$ 89.69K | C$ -4.60M | C$ 0.00 |
| Operating Income | C$ -9.81M | C$ -30.35M | C$ -40.58K |
| EBITDA | C$ -21.80M | C$ -25.76M | C$ -40.58K |
| Net Income | C$ -22.44M | C$ -30.38M | C$ -40.58K |
| Balance Sheet | |||
| Cash & Short-Term Investments | C$ 1.06M | C$ 9.40M | C$ 1.62M |
| Total Assets | C$ 4.06M | C$ 14.24M | C$ 1.94M |
| Total Debt | C$ 389.35K | C$ 456.33K | C$ 0.00 |
| Net Debt | C$ -666.30K | C$ -8.95M | C$ -1.62M |
| Total Liabilities | C$ 918.46K | C$ 1.04M | C$ 41.11K |
| Stockholders' Equity | C$ 3.14M | C$ 13.20M | C$ 1.90M |
| Cash Flow | |||
| Free Cash Flow | C$ -7.98M | C$ -10.45M | C$ -75.02K |
| Operating Cash Flow | C$ -7.88M | C$ -10.42M | C$ -75.02K |
| Investing Cash Flow | C$ -2.03M | C$ -396.70K | C$ -250.00K |
| Financing Cash Flow | C$ 1.56M | C$ 18.60M | C$ 1.94M |
HAVN Life Sciences Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.